Current indications for pancreas or islet transplant

Diabetes, Obesity and Metabolism

Volumn 8, Issue 1, 2006, Pages 1-7

  Ryan, Edmond A ^a   Bigam, David ^a   Shapiro, A M James ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Diabetes; Indications; Islet; Pancreas; Transplantation

Indexed keywords

ANTIHYPERTENSIVE AGENT; CODEINE; COLESTYRAMINE; DIPHENOXYLATE; GRANULOCYTE COLONY STIMULATING FACTOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMMUNOSUPPRESSIVE AGENT; INSULIN; RAPAMYCIN; TRIAMCINOLONE ACETONIDE;

ABDOMINAL DRAINAGE; ABDOMINAL INFECTION; ABDOMINAL PAIN; ABSCESS; ACNE; AGE; ANTINEOPLASTIC ACTIVITY; ARTERY INTIMA PROLIFERATION; ARTERY THROMBOSIS; BLADDER ASPIRATION; BLOOD GLUCOSE MONITORING; BODY WEIGHT DISORDER; CANCER RISK; CANNULATION; CORONARY ARTERY ATHEROSCLEROSIS; CYTOMEGALOVIRUS INFECTION; DIABETIC NEUROPATHY; DIABETIC RETINOPATHY; DIARRHEA; DISEASE EXACERBATION; DISEASE SEVERITY; DRUG POTENCY; ESOPHAGITIS; GLUCOSE HOMEOSTASIS; GRAFT REJECTION; GRAFT SURVIVAL; HEALTH CARE COST; HOSPITALIZATION; HUMAN; HYPOGLYCEMIA; IMMUNOSUPPRESSIVE TREATMENT; INFECTION RISK; INSULIN DEPENDENCE; INSULIN DEPENDENT DIABETES MELLITUS; INTERMETHOD COMPARISON; KIDNEY BIOPSY; KIDNEY DYSFUNCTION; LENGTH OF STAY; LIFESTYLE; LIVER DYSFUNCTION; MEDICAL SPECIALIST; MENTAL DISEASE; MOUTH HYGIENE; MOUTH ULCER; NEPHROTOXICITY; OBESITY; PANCREAS ABSCESS; PANCREAS ISLET TRANSPLANTATION; PANCREAS TRANSPLANTATION; PANCREATITIS; PATIENT REFERRAL; PNEUMONIA; PORTAL VEIN THROMBOSIS; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE PERIOD; PROTEINURIA; QUALITY OF LIFE; RECURRENT DISEASE; RETINA HEMORRHAGE; REVIEW; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; RISK FACTOR; RISK REDUCTION; SKIN CANCER; SUN EXPOSURE; SURGICAL MORTALITY; SURGICAL RISK; SURVIVAL RATE; SURVIVAL TIME; TREATMENT INDICATION; TREATMENT OUTCOME; VEIN THROMBOSIS; VITREOUS HEMORRHAGE; WEIGHT REDUCTION;

EID: 33645997027     PISSN: 14628902     EISSN: 14631326     Source Type: Journal    
DOI: 10.1111/j.1463-1326.2004.00460.x     Document Type: Review

References (42)

1. American Diabetes Association Pancreas Transplantation for patients with Type 1 diabetes. Diabetes Care 2004; 27 (Suppl. 1): S105.
2. Shapiro AMJ, Lakey JRT, Ryan EA et al. Islet transplantation in seven patients with Type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 2000; 343: 230-238.
3. Carpenter CB. Improving the success of organ transplantation. N Engl J Med 2000; 342: 647-648.
4. Sutherland DER, Gruessner RW, Dunn DL et al. Lessons learned from more than 1,000 pancreas transplants at a single institution. Ann Surg 2001; 233: 463-501.
5. Venstrom JM, McBride MA, Rother KI, Hirshberg B, Orchard TJ, Harlan DM. Survival after pancreas transplantation in patients with diabetes and preserved kidney function. JAMA 2003; 290: 2817-2823.
6. Reddy KS, Stablein D, Taranto S et al. Long-term survival following simultaneous kidney-pancreas transplantation versus kidney transplantation alone in patients with type 1 diabetes mellitus and renal failure. Am J Kidney Dis 2003; 41: 464-470.
7. Brendel MD, Hering BJ, Schulz AO, Bretzel RG. International islet transplant registry report 1999. 1-20. Justus-Liebig-University of Giessen.
8. Humar A, Kandaswamy R, Granger D, Gruessner RW, Gruessner AC, Sutherland DER. Decreased surgical risks of pancreas transplantation in the modern era. Ann Surg 2000; 231: 269-275.
9. Becker BN, Odorico JS, Becker YT et al. Simultaneous pancreas-kidney and pancreas transplantation. J Am Soc Nephrol 2001; 12: 2517-2527.
10. Ryan EA, Lakey JRT, Paty BW et al. Successful islet transplantation. Continued insulin reserve provides long-term glycemic control. Diabetes 2002; 51: 2148-2157.
11. Königsrainer A, Miller K, Steurer W et al. Does pancreas transplantation influence the course of diabetic retinopathy? Diabetologia 1991; 34 (Suppl. 1): S86-S88.
12. Koznarova R, Saudek F, Sosna T et al. Beneficial effects of pancreas and kidney transplantation on advanced diabetic retinopathy. Cell Transplant 2000; 9: 903-908.
13. Giannarelli R, Coppelli A, Sartini MS et al. Early improvement of unstable diabetic retinopathy after solitary pancreas transplantation. Diabetes Care 2002; 25: 2358-2359.
14. Chow VCC, Pai RP, Chapman JR et al. Diabetic retinopathy after combined kidney-pancreas transplantation. Clin Transplant 2003; 13: 356-362.
15. Fioretto P, Steffes MW, Sutherland DER, Goetz FC, Mauer M. Reversal of lesions of diabetic nephropathy after pancreas transplantation. N Engl J Med 1998; 339: 69-75.
16. Ojo AO, Held PJ, Port FK et al. Chronic renal failure after transplantation of a nonrenal organ. N Engl J Med 2003; 349: 931-940.
17. Jukema JW, Smets YFC, van der Pijl JW et al. Impact of simultaneous pancreas and kidney transplantation on progression of coronary atherosclerosis in patients with end-stage renal failure due to Type 1 diabetes. Diabetes Care 2002; 25: 906-911.
18. Larsen JL, Ratanasuwan T, Burkman T et al. Carotid intima media thickness decreases after pancreas transplantation. Transplantation 2003; 73: 936-940.
19. Fiorina P, Folli F, Bertuzzi F et al. Long-term beneficial effect of islet transplantation on diabetic macro-/microangiopathy in type 1 diabetic kidney-transplanted patients. Diabetes Care 2003; 26: 1129-1136.
20. Navarro X, Sutherland DER, Kennedy WR. Long-term effects of pancreatic transplantation on diabetic neuropathy. Ann Neurol 2003; 42: 727-736.
21. Müller-Felber W, Landgraf R, Scheuer R et al. Diabetic neuropathy 3 years after successful pancreas and kidney transplantation. Diabetes 1993; 42: 1482-1486.
22. Diem P, Redmon JB, Abid M et al. Glucagon catecholamine and pancreatic polypeptide secretion in Type 1 diabetic recipients of pancreas allografts. J Clin Invest 1990; 86: 2008-2013.
23. Paty BW, Lanz K, Kendall DM, Sutherland DE, Robertson RP. Restored hypoglycemic counterregulation is stable in successful pancreas transplant recipients for up to 19 years after transplantation. Transplantation 2001; 72: 1103-1107.
24. Paty BW, Ryan EA, Shapiro AMJ, Lakey JRT, Robertson RP. Intrahepatic islet transplantation in type 1 diabetic patients does not restore hypoglycemic hormonal counterregulation or symptom recognition after insulin independence. Diabetes 2002; 51: 3428-3434.
25. Ryan EA, Shandro T, Green K et al. Assessment of the severity of hypoglycemia and glycemic lability in Type 1 diabetic subjects undergoing islet transplantation. Diabetes 2004; 53: 955-962.
26. Abbott KC, Oliver JD III, Hypolite I et al. Hospitalizations for bacterial septicemia after renal transplantation in the United States. Am J Nephrol 2001; 21: 120-127.
27. Abbott KC, Hypolite I, Poropatich RK et al. Hospitalizations for fungal infections after renal transplantation in the United States. Transpl Infect Dis 2001; 3: 203-211.
28. Eckhard M, Martin I, Eich T et al. Incidence of cytomegalovirus infections after immunosuppression induction in clinical islet transplantation and impact on graft function. Transplant Proc 2002; 34: 1922-1924.
29. Lutz J, Heemann U. Tumours after kidney transplantation. Curr Opin Urol 2003; 13: 105-109.
30. Euvrard S, Kanitakis J, Claudy A. Skin cancers after organ transplantation. N Engl J Med 2003; 348: 1681-1691.
31. Mita MM, Mita A, Rowinsky EK. The molecular target of rapamycin (mTOR) as a therapeutic target against cancer. Cancer Biol Ther 2003; 4 (Suppl. 1): S169-S177.
32. Robertson RP, Davis C, Larsen J, Stratta R, Sutherland DER. Pancreas and islet transplantation for patients with diabetes. Diabetes Care 2000; 23: 112-116.
33. Johnson JA, Kotovych M, Ryan EA, Shapiro AM. Reduced fear of hypoglycemia in successful islet transplantation. Diabetes Care 2004; 27: 624-625.
34. Service FJ, Molnar GD, Rosevear JW, Ackerman E, Gatewood LC, Taylor WF. Mean amplitude of glycemic excursions, a measure of diabetic instability. Diabetes 1970; 19: 644-655.
35. Kessler L, Passemard R, Oberholzer J et al. Reduction of blood glucose variability in Type 1 diabetic patients treated by pancreatic islet transplantation. Diabetes Care 2002; 25: 2256-2262.
36. Diabetes Research in Children Network Study Group. Accuracy of the GlucoWatch G2 Biographer and the continuous glucose monitoring system during hypoglycemia: Experience of Diabetes Research in Children Network. Diabetes Care 2004; 27: 722-726.
37. Allen C, LeCaire T, Palta M, Daniels K, Meredith M, D'Alesso DJ. Risk factors for frequent and severe hypoglycemia in Type 1 diabetes. Diabetes Care 2001; 24: 1878-1881.
38. Pramming S, Thorsteinsson B, Bendtson I, Binder C. Symptomatic hypoglycaemia in 411 Type 1 diabetic patients. Diabet Med 1991; 8: 217-222.
39. ter Braak EWMT, Stolk RP, Appelman AMMF, van Haeften TW, van de Laak MF, Erkelens DW. Clinical characteristics of Type 1 diabetic patients with and without severe hypoglycemia. Diabetes Care 2000; 23: 1467-1471.
40. Lin K, Stewart D, Cooper S, Davis CL. Pre-transplant cardiac testing for kidney-pancreas transplant candidates and association with cardiac outcomes. Clin Transplant 2001; 15: 269-275.
41. Larsen J, Brekke M, Sandvik L, Arnesen H, Hanssen KF, Dahl-Jorgensen K. Silent coronary atheromatosis in type 1 diabetic patients and its relation to long-term glycemic control. Diabetes 2002; 51: 2637-2641.
42. de Mattos AM, Olyaei AJ, Bennett WM. Nephrotoxicity of immunosuppressive drugs: Long-term consequences and challenges for the future. Am J Kidney Dis 2000; 35: 333-346.